Transcatheter Fontan Stenting: Impact on Hepatic Stiffness and Exercise Capacity
Recruiting
Observational Study
Single-ventricle
Stenosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 12 – 21
- Sex
- Any
- Study type
- Observational
- Participants needed
- 20 (estimated)
- Sponsor
- Children's Hospital Los Angeles · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study is to assess the clinical impact following Fontan stent placement for extracardiac Fontan conduit (EFC) stenosis in patients with single-ventricle Fontan-palliated patients ages 12-21 years old.
The main question it aims to:
-Assess changes in exercise capacity by cardiopulmonary exercise testing and liver stiffness assessed by shear wave elastography before …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Functionally single-ventricle Fontan-palliated patients undergoing clinically indicated cardiac catheterization
* Anticipated Fontan stent placement for extracardiac Fontan conduit stenosis at the discretion of the primary operator
* Weight ≥ 50 kg
* 12-21 years of age
Exclus…
Contacts